nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—CYP1A2—Anagrelide—hematologic cancer	0.1	0.217	CbGbCtD
Atropine—CYP1A2—Carmustine—hematologic cancer	0.0525	0.114	CbGbCtD
Atropine—CYP1A2—Methoxsalen—hematologic cancer	0.0447	0.0969	CbGbCtD
Atropine—CYP1A2—Bortezomib—hematologic cancer	0.0425	0.0922	CbGbCtD
Atropine—CYP1A2—Daunorubicin—hematologic cancer	0.0406	0.0882	CbGbCtD
Atropine—CYP1A2—Alitretinoin—hematologic cancer	0.0398	0.0864	CbGbCtD
Atropine—CYP1A2—Thalidomide—hematologic cancer	0.037	0.0803	CbGbCtD
Atropine—CYP1A2—Dacarbazine—hematologic cancer	0.0318	0.0691	CbGbCtD
Atropine—CYP1A2—Imatinib—hematologic cancer	0.0311	0.0676	CbGbCtD
Atropine—CYP1A2—Dasatinib—hematologic cancer	0.025	0.0543	CbGbCtD
Atropine—CYP1A2—Etoposide—hematologic cancer	0.0156	0.0338	CbGbCtD
Atropine—Urticaria—Prednisolone—hematologic cancer	5.69e-05	0.00013	CcSEcCtD
Atropine—Asthenia—Cisplatin—hematologic cancer	5.68e-05	0.000129	CcSEcCtD
Atropine—Fatigue—Triamcinolone—hematologic cancer	5.68e-05	0.000129	CcSEcCtD
Atropine—Sweating—Doxorubicin—hematologic cancer	5.66e-05	0.000129	CcSEcCtD
Atropine—Rash—Vincristine—hematologic cancer	5.65e-05	0.000129	CcSEcCtD
Atropine—Dermatitis—Vincristine—hematologic cancer	5.64e-05	0.000129	CcSEcCtD
Atropine—Pain—Triamcinolone—hematologic cancer	5.63e-05	0.000128	CcSEcCtD
Atropine—Headache—Vincristine—hematologic cancer	5.61e-05	0.000128	CcSEcCtD
Atropine—Loss of consciousness—Prednisone—hematologic cancer	5.6e-05	0.000128	CcSEcCtD
Atropine—Hypotension—Betamethasone—hematologic cancer	5.58e-05	0.000127	CcSEcCtD
Atropine—Hypotension—Dexamethasone—hematologic cancer	5.58e-05	0.000127	CcSEcCtD
Atropine—Nausea—Carmustine—hematologic cancer	5.57e-05	0.000127	CcSEcCtD
Atropine—Vomiting—Mitoxantrone—hematologic cancer	5.55e-05	0.000126	CcSEcCtD
Atropine—Vomiting—Irinotecan—hematologic cancer	5.55e-05	0.000126	CcSEcCtD
Atropine—Nausea—Alitretinoin—hematologic cancer	5.52e-05	0.000126	CcSEcCtD
Atropine—Convulsion—Prednisone—hematologic cancer	5.52e-05	0.000126	CcSEcCtD
Atropine—Rash—Mitoxantrone—hematologic cancer	5.5e-05	0.000125	CcSEcCtD
Atropine—Rash—Irinotecan—hematologic cancer	5.5e-05	0.000125	CcSEcCtD
Atropine—Dermatitis—Mitoxantrone—hematologic cancer	5.5e-05	0.000125	CcSEcCtD
Atropine—Dermatitis—Irinotecan—hematologic cancer	5.5e-05	0.000125	CcSEcCtD
Atropine—Headache—Mitoxantrone—hematologic cancer	5.47e-05	0.000124	CcSEcCtD
Atropine—Headache—Irinotecan—hematologic cancer	5.47e-05	0.000124	CcSEcCtD
Atropine—Nausea—Ifosfamide—hematologic cancer	5.46e-05	0.000124	CcSEcCtD
Atropine—Feeling abnormal—Triamcinolone—hematologic cancer	5.42e-05	0.000124	CcSEcCtD
Atropine—Diarrhoea—Cisplatin—hematologic cancer	5.42e-05	0.000123	CcSEcCtD
Atropine—Anxiety—Prednisone—hematologic cancer	5.41e-05	0.000123	CcSEcCtD
Atropine—Vomiting—Gemcitabine—hematologic cancer	5.4e-05	0.000123	CcSEcCtD
Atropine—Insomnia—Dexamethasone—hematologic cancer	5.4e-05	0.000123	CcSEcCtD
Atropine—Insomnia—Betamethasone—hematologic cancer	5.4e-05	0.000123	CcSEcCtD
Atropine—Bradycardia—Doxorubicin—hematologic cancer	5.39e-05	0.000123	CcSEcCtD
Atropine—Mental disorder—Methotrexate—hematologic cancer	5.36e-05	0.000122	CcSEcCtD
Atropine—Rash—Gemcitabine—hematologic cancer	5.36e-05	0.000122	CcSEcCtD
Atropine—Dermatitis—Gemcitabine—hematologic cancer	5.35e-05	0.000122	CcSEcCtD
Atropine—Hypersensitivity—Etoposide—hematologic cancer	5.35e-05	0.000122	CcSEcCtD
Atropine—Erythema—Methotrexate—hematologic cancer	5.33e-05	0.000121	CcSEcCtD
Atropine—Headache—Gemcitabine—hematologic cancer	5.32e-05	0.000121	CcSEcCtD
Atropine—Nausea—Vincristine—hematologic cancer	5.32e-05	0.000121	CcSEcCtD
Atropine—Flushing—Epirubicin—hematologic cancer	5.31e-05	0.000121	CcSEcCtD
Atropine—Hypersensitivity—Prednisolone—hematologic cancer	5.27e-05	0.00012	CcSEcCtD
Atropine—Dyspepsia—Dexamethasone—hematologic cancer	5.26e-05	0.00012	CcSEcCtD
Atropine—Dyspepsia—Betamethasone—hematologic cancer	5.26e-05	0.00012	CcSEcCtD
Atropine—Urticaria—Triamcinolone—hematologic cancer	5.23e-05	0.000119	CcSEcCtD
Atropine—Dysgeusia—Methotrexate—hematologic cancer	5.22e-05	0.000119	CcSEcCtD
Atropine—Asthenia—Etoposide—hematologic cancer	5.21e-05	0.000119	CcSEcCtD
Atropine—Body temperature increased—Triamcinolone—hematologic cancer	5.2e-05	0.000119	CcSEcCtD
Atropine—Anaphylactic shock—Prednisone—hematologic cancer	5.2e-05	0.000118	CcSEcCtD
Atropine—Oedema—Prednisone—hematologic cancer	5.2e-05	0.000118	CcSEcCtD
Atropine—Nausea—Irinotecan—hematologic cancer	5.18e-05	0.000118	CcSEcCtD
Atropine—Nausea—Mitoxantrone—hematologic cancer	5.18e-05	0.000118	CcSEcCtD
Atropine—Fatigue—Betamethasone—hematologic cancer	5.15e-05	0.000117	CcSEcCtD
Atropine—Fatigue—Dexamethasone—hematologic cancer	5.15e-05	0.000117	CcSEcCtD
Atropine—Pruritus—Etoposide—hematologic cancer	5.13e-05	0.000117	CcSEcCtD
Atropine—Shock—Prednisone—hematologic cancer	5.12e-05	0.000117	CcSEcCtD
Atropine—Arrhythmia—Epirubicin—hematologic cancer	5.12e-05	0.000117	CcSEcCtD
Atropine—Pain—Betamethasone—hematologic cancer	5.11e-05	0.000116	CcSEcCtD
Atropine—Pain—Dexamethasone—hematologic cancer	5.11e-05	0.000116	CcSEcCtD
Atropine—Tachycardia—Prednisone—hematologic cancer	5.08e-05	0.000116	CcSEcCtD
Atropine—Nausea—Gemcitabine—hematologic cancer	5.05e-05	0.000115	CcSEcCtD
Atropine—Vomiting—Cisplatin—hematologic cancer	5.04e-05	0.000115	CcSEcCtD
Atropine—Hyperhidrosis—Prednisone—hematologic cancer	5.03e-05	0.000115	CcSEcCtD
Atropine—Vision blurred—Methotrexate—hematologic cancer	5.02e-05	0.000114	CcSEcCtD
Atropine—Mental disorder—Epirubicin—hematologic cancer	5.02e-05	0.000114	CcSEcCtD
Atropine—Rash—Cisplatin—hematologic cancer	4.99e-05	0.000114	CcSEcCtD
Atropine—Dermatitis—Cisplatin—hematologic cancer	4.99e-05	0.000114	CcSEcCtD
Atropine—Erythema—Epirubicin—hematologic cancer	4.98e-05	0.000114	CcSEcCtD
Atropine—Diarrhoea—Etoposide—hematologic cancer	4.97e-05	0.000113	CcSEcCtD
Atropine—Feeling abnormal—Dexamethasone—hematologic cancer	4.92e-05	0.000112	CcSEcCtD
Atropine—Feeling abnormal—Betamethasone—hematologic cancer	4.92e-05	0.000112	CcSEcCtD
Atropine—Flushing—Doxorubicin—hematologic cancer	4.92e-05	0.000112	CcSEcCtD
Atropine—Tension—Epirubicin—hematologic cancer	4.89e-05	0.000111	CcSEcCtD
Atropine—Gastrointestinal pain—Betamethasone—hematologic cancer	4.88e-05	0.000111	CcSEcCtD
Atropine—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.88e-05	0.000111	CcSEcCtD
Atropine—Dysgeusia—Epirubicin—hematologic cancer	4.88e-05	0.000111	CcSEcCtD
Atropine—Hypersensitivity—Triamcinolone—hematologic cancer	4.85e-05	0.00011	CcSEcCtD
Atropine—Nervousness—Epirubicin—hematologic cancer	4.84e-05	0.00011	CcSEcCtD
Atropine—Dizziness—Etoposide—hematologic cancer	4.8e-05	0.000109	CcSEcCtD
Atropine—Vertigo—Methotrexate—hematologic cancer	4.79e-05	0.000109	CcSEcCtD
Atropine—Urticaria—Dexamethasone—hematologic cancer	4.74e-05	0.000108	CcSEcCtD
Atropine—Urticaria—Betamethasone—hematologic cancer	4.74e-05	0.000108	CcSEcCtD
Atropine—Dizziness—Prednisolone—hematologic cancer	4.73e-05	0.000108	CcSEcCtD
Atropine—Arrhythmia—Doxorubicin—hematologic cancer	4.73e-05	0.000108	CcSEcCtD
Atropine—Asthenia—Triamcinolone—hematologic cancer	4.72e-05	0.000108	CcSEcCtD
Atropine—Abdominal pain—Betamethasone—hematologic cancer	4.72e-05	0.000108	CcSEcCtD
Atropine—Body temperature increased—Betamethasone—hematologic cancer	4.72e-05	0.000108	CcSEcCtD
Atropine—Body temperature increased—Dexamethasone—hematologic cancer	4.72e-05	0.000108	CcSEcCtD
Atropine—Abdominal pain—Dexamethasone—hematologic cancer	4.72e-05	0.000108	CcSEcCtD
Atropine—Nausea—Cisplatin—hematologic cancer	4.71e-05	0.000107	CcSEcCtD
Atropine—Insomnia—Prednisone—hematologic cancer	4.7e-05	0.000107	CcSEcCtD
Atropine—Vision blurred—Epirubicin—hematologic cancer	4.7e-05	0.000107	CcSEcCtD
Atropine—Pruritus—Triamcinolone—hematologic cancer	4.66e-05	0.000106	CcSEcCtD
Atropine—Mental disorder—Doxorubicin—hematologic cancer	4.64e-05	0.000106	CcSEcCtD
Atropine—Convulsion—Methotrexate—hematologic cancer	4.61e-05	0.000105	CcSEcCtD
Atropine—Vomiting—Etoposide—hematologic cancer	4.61e-05	0.000105	CcSEcCtD
Atropine—Erythema—Doxorubicin—hematologic cancer	4.61e-05	0.000105	CcSEcCtD
Atropine—Agitation—Epirubicin—hematologic cancer	4.58e-05	0.000104	CcSEcCtD
Atropine—Dyspepsia—Prednisone—hematologic cancer	4.58e-05	0.000104	CcSEcCtD
Atropine—Rash—Etoposide—hematologic cancer	4.58e-05	0.000104	CcSEcCtD
Atropine—Dermatitis—Etoposide—hematologic cancer	4.57e-05	0.000104	CcSEcCtD
Atropine—Headache—Etoposide—hematologic cancer	4.55e-05	0.000104	CcSEcCtD
Atropine—Chest pain—Methotrexate—hematologic cancer	4.53e-05	0.000103	CcSEcCtD
Atropine—Tension—Doxorubicin—hematologic cancer	4.53e-05	0.000103	CcSEcCtD
Atropine—Dysgeusia—Doxorubicin—hematologic cancer	4.52e-05	0.000103	CcSEcCtD
Atropine—Rash—Prednisolone—hematologic cancer	4.51e-05	0.000103	CcSEcCtD
Atropine—Dermatitis—Prednisolone—hematologic cancer	4.51e-05	0.000103	CcSEcCtD
Atropine—Fatigue—Prednisone—hematologic cancer	4.48e-05	0.000102	CcSEcCtD
Atropine—Headache—Prednisolone—hematologic cancer	4.48e-05	0.000102	CcSEcCtD
Atropine—Nervousness—Doxorubicin—hematologic cancer	4.48e-05	0.000102	CcSEcCtD
Atropine—Vertigo—Epirubicin—hematologic cancer	4.48e-05	0.000102	CcSEcCtD
Atropine—Syncope—Epirubicin—hematologic cancer	4.47e-05	0.000102	CcSEcCtD
Atropine—Constipation—Prednisone—hematologic cancer	4.45e-05	0.000101	CcSEcCtD
Atropine—Palpitations—Epirubicin—hematologic cancer	4.4e-05	0.0001	CcSEcCtD
Atropine—Confusional state—Methotrexate—hematologic cancer	4.38e-05	9.98e-05	CcSEcCtD
Atropine—Loss of consciousness—Epirubicin—hematologic cancer	4.38e-05	9.98e-05	CcSEcCtD
Atropine—Dizziness—Triamcinolone—hematologic cancer	4.35e-05	9.91e-05	CcSEcCtD
Atropine—Anaphylactic shock—Methotrexate—hematologic cancer	4.35e-05	9.9e-05	CcSEcCtD
Atropine—Vision blurred—Doxorubicin—hematologic cancer	4.35e-05	9.9e-05	CcSEcCtD
Atropine—Convulsion—Epirubicin—hematologic cancer	4.32e-05	9.84e-05	CcSEcCtD
Atropine—Nausea—Etoposide—hematologic cancer	4.31e-05	9.82e-05	CcSEcCtD
Atropine—Feeling abnormal—Prednisone—hematologic cancer	4.29e-05	9.76e-05	CcSEcCtD
Atropine—Asthenia—Dexamethasone—hematologic cancer	4.29e-05	9.76e-05	CcSEcCtD
Atropine—Asthenia—Betamethasone—hematologic cancer	4.29e-05	9.76e-05	CcSEcCtD
Atropine—Gastrointestinal pain—Prednisone—hematologic cancer	4.25e-05	9.69e-05	CcSEcCtD
Atropine—Nausea—Prednisolone—hematologic cancer	4.25e-05	9.68e-05	CcSEcCtD
Atropine—Chest pain—Epirubicin—hematologic cancer	4.24e-05	9.67e-05	CcSEcCtD
Atropine—Agitation—Doxorubicin—hematologic cancer	4.24e-05	9.65e-05	CcSEcCtD
Atropine—Anxiety—Epirubicin—hematologic cancer	4.23e-05	9.63e-05	CcSEcCtD
Atropine—Pruritus—Betamethasone—hematologic cancer	4.23e-05	9.62e-05	CcSEcCtD
Atropine—Pruritus—Dexamethasone—hematologic cancer	4.23e-05	9.62e-05	CcSEcCtD
Atropine—Hyperhidrosis—Methotrexate—hematologic cancer	4.2e-05	9.57e-05	CcSEcCtD
Atropine—Vomiting—Triamcinolone—hematologic cancer	4.19e-05	9.53e-05	CcSEcCtD
Atropine—Rash—Triamcinolone—hematologic cancer	4.15e-05	9.45e-05	CcSEcCtD
Atropine—Dry mouth—Epirubicin—hematologic cancer	4.15e-05	9.45e-05	CcSEcCtD
Atropine—Dermatitis—Triamcinolone—hematologic cancer	4.15e-05	9.44e-05	CcSEcCtD
Atropine—Vertigo—Doxorubicin—hematologic cancer	4.14e-05	9.44e-05	CcSEcCtD
Atropine—Syncope—Doxorubicin—hematologic cancer	4.14e-05	9.42e-05	CcSEcCtD
Atropine—Urticaria—Prednisone—hematologic cancer	4.13e-05	9.41e-05	CcSEcCtD
Atropine—Headache—Triamcinolone—hematologic cancer	4.12e-05	9.39e-05	CcSEcCtD
Atropine—Abdominal pain—Prednisone—hematologic cancer	4.11e-05	9.37e-05	CcSEcCtD
Atropine—Body temperature increased—Prednisone—hematologic cancer	4.11e-05	9.37e-05	CcSEcCtD
Atropine—Confusional state—Epirubicin—hematologic cancer	4.1e-05	9.34e-05	CcSEcCtD
Atropine—Diarrhoea—Betamethasone—hematologic cancer	4.09e-05	9.31e-05	CcSEcCtD
Atropine—Diarrhoea—Dexamethasone—hematologic cancer	4.09e-05	9.31e-05	CcSEcCtD
Atropine—Palpitations—Doxorubicin—hematologic cancer	4.08e-05	9.28e-05	CcSEcCtD
Atropine—Oedema—Epirubicin—hematologic cancer	4.07e-05	9.27e-05	CcSEcCtD
Atropine—Anaphylactic shock—Epirubicin—hematologic cancer	4.07e-05	9.27e-05	CcSEcCtD
Atropine—Hypotension—Methotrexate—hematologic cancer	4.06e-05	9.25e-05	CcSEcCtD
Atropine—Loss of consciousness—Doxorubicin—hematologic cancer	4.05e-05	9.23e-05	CcSEcCtD
Atropine—Shock—Epirubicin—hematologic cancer	4e-05	9.12e-05	CcSEcCtD
Atropine—Convulsion—Doxorubicin—hematologic cancer	4e-05	9.1e-05	CcSEcCtD
Atropine—Tachycardia—Epirubicin—hematologic cancer	3.97e-05	9.04e-05	CcSEcCtD
Atropine—Dizziness—Dexamethasone—hematologic cancer	3.95e-05	9e-05	CcSEcCtD
Atropine—Dizziness—Betamethasone—hematologic cancer	3.95e-05	9e-05	CcSEcCtD
Atropine—Hyperhidrosis—Epirubicin—hematologic cancer	3.93e-05	8.96e-05	CcSEcCtD
Atropine—Insomnia—Methotrexate—hematologic cancer	3.93e-05	8.95e-05	CcSEcCtD
Atropine—Chest pain—Doxorubicin—hematologic cancer	3.93e-05	8.94e-05	CcSEcCtD
Atropine—Anxiety—Doxorubicin—hematologic cancer	3.91e-05	8.91e-05	CcSEcCtD
Atropine—Nausea—Triamcinolone—hematologic cancer	3.91e-05	8.91e-05	CcSEcCtD
Atropine—Dyspnoea—Methotrexate—hematologic cancer	3.88e-05	8.83e-05	CcSEcCtD
Atropine—Somnolence—Methotrexate—hematologic cancer	3.86e-05	8.8e-05	CcSEcCtD
Atropine—Dry mouth—Doxorubicin—hematologic cancer	3.84e-05	8.75e-05	CcSEcCtD
Atropine—Hypersensitivity—Prednisone—hematologic cancer	3.83e-05	8.73e-05	CcSEcCtD
Atropine—Dyspepsia—Methotrexate—hematologic cancer	3.83e-05	8.72e-05	CcSEcCtD
Atropine—Hypotension—Epirubicin—hematologic cancer	3.8e-05	8.66e-05	CcSEcCtD
Atropine—Vomiting—Betamethasone—hematologic cancer	3.8e-05	8.65e-05	CcSEcCtD
Atropine—Vomiting—Dexamethasone—hematologic cancer	3.8e-05	8.65e-05	CcSEcCtD
Atropine—Confusional state—Doxorubicin—hematologic cancer	3.8e-05	8.64e-05	CcSEcCtD
Atropine—Rash—Dexamethasone—hematologic cancer	3.77e-05	8.58e-05	CcSEcCtD
Atropine—Rash—Betamethasone—hematologic cancer	3.77e-05	8.58e-05	CcSEcCtD
Atropine—Oedema—Doxorubicin—hematologic cancer	3.76e-05	8.57e-05	CcSEcCtD
Atropine—Anaphylactic shock—Doxorubicin—hematologic cancer	3.76e-05	8.57e-05	CcSEcCtD
Atropine—Dermatitis—Dexamethasone—hematologic cancer	3.76e-05	8.57e-05	CcSEcCtD
Atropine—Dermatitis—Betamethasone—hematologic cancer	3.76e-05	8.57e-05	CcSEcCtD
Atropine—Fatigue—Methotrexate—hematologic cancer	3.75e-05	8.54e-05	CcSEcCtD
Atropine—Headache—Dexamethasone—hematologic cancer	3.74e-05	8.52e-05	CcSEcCtD
Atropine—Headache—Betamethasone—hematologic cancer	3.74e-05	8.52e-05	CcSEcCtD
Atropine—Asthenia—Prednisone—hematologic cancer	3.73e-05	8.5e-05	CcSEcCtD
Atropine—Pain—Methotrexate—hematologic cancer	3.72e-05	8.47e-05	CcSEcCtD
Atropine—Shock—Doxorubicin—hematologic cancer	3.7e-05	8.43e-05	CcSEcCtD
Atropine—Pruritus—Prednisone—hematologic cancer	3.68e-05	8.38e-05	CcSEcCtD
Atropine—Insomnia—Epirubicin—hematologic cancer	3.68e-05	8.38e-05	CcSEcCtD
Atropine—Tachycardia—Doxorubicin—hematologic cancer	3.67e-05	8.37e-05	CcSEcCtD
Atropine—Hyperhidrosis—Doxorubicin—hematologic cancer	3.64e-05	8.29e-05	CcSEcCtD
Atropine—Dyspnoea—Epirubicin—hematologic cancer	3.63e-05	8.26e-05	CcSEcCtD
Atropine—Somnolence—Epirubicin—hematologic cancer	3.62e-05	8.24e-05	CcSEcCtD
Atropine—Feeling abnormal—Methotrexate—hematologic cancer	3.58e-05	8.16e-05	CcSEcCtD
Atropine—Dyspepsia—Epirubicin—hematologic cancer	3.58e-05	8.16e-05	CcSEcCtD
Atropine—Diarrhoea—Prednisone—hematologic cancer	3.56e-05	8.11e-05	CcSEcCtD
Atropine—Gastrointestinal pain—Methotrexate—hematologic cancer	3.55e-05	8.1e-05	CcSEcCtD
Atropine—Nausea—Betamethasone—hematologic cancer	3.55e-05	8.08e-05	CcSEcCtD
Atropine—Nausea—Dexamethasone—hematologic cancer	3.55e-05	8.08e-05	CcSEcCtD
Atropine—Hypotension—Doxorubicin—hematologic cancer	3.52e-05	8.01e-05	CcSEcCtD
Atropine—Fatigue—Epirubicin—hematologic cancer	3.51e-05	7.99e-05	CcSEcCtD
Atropine—Constipation—Epirubicin—hematologic cancer	3.48e-05	7.92e-05	CcSEcCtD
Atropine—Pain—Epirubicin—hematologic cancer	3.48e-05	7.92e-05	CcSEcCtD
Atropine—Urticaria—Methotrexate—hematologic cancer	3.45e-05	7.87e-05	CcSEcCtD
Atropine—Dizziness—Prednisone—hematologic cancer	3.44e-05	7.83e-05	CcSEcCtD
Atropine—Abdominal pain—Methotrexate—hematologic cancer	3.44e-05	7.83e-05	CcSEcCtD
Atropine—Body temperature increased—Methotrexate—hematologic cancer	3.44e-05	7.83e-05	CcSEcCtD
Atropine—Insomnia—Doxorubicin—hematologic cancer	3.4e-05	7.75e-05	CcSEcCtD
Atropine—Dyspnoea—Doxorubicin—hematologic cancer	3.36e-05	7.64e-05	CcSEcCtD
Atropine—Feeling abnormal—Epirubicin—hematologic cancer	3.35e-05	7.64e-05	CcSEcCtD
Atropine—Somnolence—Doxorubicin—hematologic cancer	3.35e-05	7.62e-05	CcSEcCtD
Atropine—Gastrointestinal pain—Epirubicin—hematologic cancer	3.33e-05	7.58e-05	CcSEcCtD
Atropine—Dyspepsia—Doxorubicin—hematologic cancer	3.31e-05	7.55e-05	CcSEcCtD
Atropine—Vomiting—Prednisone—hematologic cancer	3.31e-05	7.53e-05	CcSEcCtD
Atropine—Rash—Prednisone—hematologic cancer	3.28e-05	7.47e-05	CcSEcCtD
Atropine—Dermatitis—Prednisone—hematologic cancer	3.28e-05	7.46e-05	CcSEcCtD
Atropine—Headache—Prednisone—hematologic cancer	3.26e-05	7.42e-05	CcSEcCtD
Atropine—Fatigue—Doxorubicin—hematologic cancer	3.25e-05	7.39e-05	CcSEcCtD
Atropine—Urticaria—Epirubicin—hematologic cancer	3.23e-05	7.36e-05	CcSEcCtD
Atropine—Pain—Doxorubicin—hematologic cancer	3.22e-05	7.33e-05	CcSEcCtD
Atropine—Constipation—Doxorubicin—hematologic cancer	3.22e-05	7.33e-05	CcSEcCtD
Atropine—Abdominal pain—Epirubicin—hematologic cancer	3.22e-05	7.32e-05	CcSEcCtD
Atropine—Body temperature increased—Epirubicin—hematologic cancer	3.22e-05	7.32e-05	CcSEcCtD
Atropine—Hypersensitivity—Methotrexate—hematologic cancer	3.2e-05	7.29e-05	CcSEcCtD
Atropine—Asthenia—Methotrexate—hematologic cancer	3.12e-05	7.1e-05	CcSEcCtD
Atropine—Feeling abnormal—Doxorubicin—hematologic cancer	3.1e-05	7.06e-05	CcSEcCtD
Atropine—Nausea—Prednisone—hematologic cancer	3.09e-05	7.04e-05	CcSEcCtD
Atropine—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.08e-05	7.01e-05	CcSEcCtD
Atropine—Pruritus—Methotrexate—hematologic cancer	3.08e-05	7e-05	CcSEcCtD
Atropine—Hypersensitivity—Epirubicin—hematologic cancer	3e-05	6.83e-05	CcSEcCtD
Atropine—Urticaria—Doxorubicin—hematologic cancer	2.99e-05	6.81e-05	CcSEcCtD
Atropine—Abdominal pain—Doxorubicin—hematologic cancer	2.98e-05	6.78e-05	CcSEcCtD
Atropine—Body temperature increased—Doxorubicin—hematologic cancer	2.98e-05	6.78e-05	CcSEcCtD
Atropine—Diarrhoea—Methotrexate—hematologic cancer	2.97e-05	6.77e-05	CcSEcCtD
Atropine—Asthenia—Epirubicin—hematologic cancer	2.92e-05	6.65e-05	CcSEcCtD
Atropine—Pruritus—Epirubicin—hematologic cancer	2.88e-05	6.56e-05	CcSEcCtD
Atropine—Dizziness—Methotrexate—hematologic cancer	2.87e-05	6.55e-05	CcSEcCtD
Atropine—Diarrhoea—Epirubicin—hematologic cancer	2.78e-05	6.34e-05	CcSEcCtD
Atropine—Hypersensitivity—Doxorubicin—hematologic cancer	2.77e-05	6.32e-05	CcSEcCtD
Atropine—Vomiting—Methotrexate—hematologic cancer	2.76e-05	6.3e-05	CcSEcCtD
Atropine—Rash—Methotrexate—hematologic cancer	2.74e-05	6.24e-05	CcSEcCtD
Atropine—Dermatitis—Methotrexate—hematologic cancer	2.74e-05	6.24e-05	CcSEcCtD
Atropine—Headache—Methotrexate—hematologic cancer	2.72e-05	6.2e-05	CcSEcCtD
Atropine—Asthenia—Doxorubicin—hematologic cancer	2.7e-05	6.15e-05	CcSEcCtD
Atropine—Dizziness—Epirubicin—hematologic cancer	2.69e-05	6.13e-05	CcSEcCtD
Atropine—Pruritus—Doxorubicin—hematologic cancer	2.66e-05	6.07e-05	CcSEcCtD
Atropine—Vomiting—Epirubicin—hematologic cancer	2.59e-05	5.89e-05	CcSEcCtD
Atropine—Nausea—Methotrexate—hematologic cancer	2.58e-05	5.88e-05	CcSEcCtD
Atropine—Diarrhoea—Doxorubicin—hematologic cancer	2.58e-05	5.87e-05	CcSEcCtD
Atropine—Rash—Epirubicin—hematologic cancer	2.56e-05	5.84e-05	CcSEcCtD
Atropine—Dermatitis—Epirubicin—hematologic cancer	2.56e-05	5.84e-05	CcSEcCtD
Atropine—Headache—Epirubicin—hematologic cancer	2.55e-05	5.8e-05	CcSEcCtD
Atropine—Dizziness—Doxorubicin—hematologic cancer	2.49e-05	5.67e-05	CcSEcCtD
Atropine—Nausea—Epirubicin—hematologic cancer	2.42e-05	5.5e-05	CcSEcCtD
Atropine—Vomiting—Doxorubicin—hematologic cancer	2.39e-05	5.45e-05	CcSEcCtD
Atropine—Rash—Doxorubicin—hematologic cancer	2.37e-05	5.41e-05	CcSEcCtD
Atropine—Dermatitis—Doxorubicin—hematologic cancer	2.37e-05	5.4e-05	CcSEcCtD
Atropine—Headache—Doxorubicin—hematologic cancer	2.36e-05	5.37e-05	CcSEcCtD
Atropine—Nausea—Doxorubicin—hematologic cancer	2.24e-05	5.09e-05	CcSEcCtD
Atropine—CHRM1—Signaling Pathways—FGFR3—hematologic cancer	8.71e-06	8.7e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MTOR—hematologic cancer	8.7e-06	8.69e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3CB—hematologic cancer	8.7e-06	8.69e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—FGFR3—hematologic cancer	8.68e-06	8.67e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—HRAS—hematologic cancer	8.68e-06	8.67e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MAPK14—hematologic cancer	8.62e-06	8.61e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	8.6e-06	8.59e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MAPK14—hematologic cancer	8.6e-06	8.59e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CDKN1B—hematologic cancer	8.53e-06	8.52e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	8.51e-06	8.5e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—NQO1—hematologic cancer	8.48e-06	8.48e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CD44—hematologic cancer	8.48e-06	8.48e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ESR1—hematologic cancer	8.46e-06	8.45e-05	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—AKT1—hematologic cancer	8.44e-06	8.43e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ESR1—hematologic cancer	8.43e-06	8.42e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CD—hematologic cancer	8.38e-06	8.37e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CASP3—hematologic cancer	8.36e-06	8.35e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—FN1—hematologic cancer	8.36e-06	8.35e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ESR1—hematologic cancer	8.35e-06	8.34e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IL2—hematologic cancer	8.35e-06	8.34e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—FN1—hematologic cancer	8.33e-06	8.32e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—HRAS—hematologic cancer	8.31e-06	8.3e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.31e-06	8.3e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—IL6—hematologic cancer	8.3e-06	8.29e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—ALB—hematologic cancer	8.27e-06	8.26e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NFKBIA—hematologic cancer	8.26e-06	8.25e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—BAD—hematologic cancer	8.26e-06	8.25e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—FN1—hematologic cancer	8.25e-06	8.24e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—BAD—hematologic cancer	8.23e-06	8.22e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NFKBIA—hematologic cancer	8.23e-06	8.22e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NOTCH1—hematologic cancer	8.18e-06	8.17e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CDKN1B—hematologic cancer	8.17e-06	8.16e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NOTCH1—hematologic cancer	8.15e-06	8.14e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	8.15e-06	8.14e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—BAD—hematologic cancer	8.15e-06	8.14e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CCND1—hematologic cancer	8.14e-06	8.13e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—JUN—hematologic cancer	8.12e-06	8.11e-05	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—AKT1—hematologic cancer	8.08e-06	8.07e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	8.07e-06	8.06e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYCS—hematologic cancer	8.03e-06	8.02e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CD80—hematologic cancer	8.01e-06	8e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CASP3—hematologic cancer	8e-06	8e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CG—hematologic cancer	8e-06	7.99e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—KIT—hematologic cancer	8e-06	7.99e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—NRAS—hematologic cancer	8e-06	7.99e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IL2—hematologic cancer	7.99e-06	7.98e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CD80—hematologic cancer	7.99e-06	7.98e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	7.98e-06	7.97e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—KIT—hematologic cancer	7.97e-06	7.96e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CG—hematologic cancer	7.97e-06	7.96e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—NRAS—hematologic cancer	7.97e-06	7.96e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—IL6—hematologic cancer	7.95e-06	7.94e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3R1—hematologic cancer	7.91e-06	7.9e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CD80—hematologic cancer	7.91e-06	7.9e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—KIT—hematologic cancer	7.89e-06	7.89e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	7.89e-06	7.89e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	7.89e-06	7.88e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CDKN1A—hematologic cancer	7.87e-06	7.86e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PTPN11—hematologic cancer	7.86e-06	7.85e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PTEN—hematologic cancer	7.85e-06	7.84e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PTPN11—hematologic cancer	7.83e-06	7.82e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CCND1—hematologic cancer	7.79e-06	7.78e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—JUN—hematologic cancer	7.77e-06	7.77e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	7.76e-06	7.75e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MAPK8—hematologic cancer	7.68e-06	7.67e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—AKT1—hematologic cancer	7.66e-06	7.65e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—MAPK3—hematologic cancer	7.66e-06	7.65e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—MAPK3—hematologic cancer	7.63e-06	7.63e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CREB1—hematologic cancer	7.61e-06	7.6e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CREB1—hematologic cancer	7.59e-06	7.58e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	7.56e-06	7.55e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CDKN1A—hematologic cancer	7.54e-06	7.53e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PTEN—hematologic cancer	7.52e-06	7.51e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—BRAF—hematologic cancer	7.52e-06	7.51e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CREB1—hematologic cancer	7.51e-06	7.51e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—BRAF—hematologic cancer	7.49e-06	7.48e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—EP300—hematologic cancer	7.49e-06	7.48e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCL2—hematologic cancer	7.45e-06	7.44e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IL6R—hematologic cancer	7.43e-06	7.42e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCL2—hematologic cancer	7.42e-06	7.42e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—BRAF—hematologic cancer	7.42e-06	7.41e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CREBBP—hematologic cancer	7.41e-06	7.41e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IL6R—hematologic cancer	7.4e-06	7.39e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CREBBP—hematologic cancer	7.39e-06	7.38e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MAPK8—hematologic cancer	7.36e-06	7.35e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCL2—hematologic cancer	7.35e-06	7.34e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—AKT1—hematologic cancer	7.34e-06	7.33e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IL6R—hematologic cancer	7.33e-06	7.32e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	7.32e-06	7.31e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CB—hematologic cancer	7.3e-06	7.3e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—SRC—hematologic cancer	7.28e-06	7.27e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.18e-06	7.17e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—EP300—hematologic cancer	7.17e-06	7.16e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—VEGFA—hematologic cancer	7.09e-06	7.08e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GSTP1—hematologic cancer	7.08e-06	7.07e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MAP2K1—hematologic cancer	7.08e-06	7.07e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MAP2K1—hematologic cancer	7.05e-06	7.05e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CD—hematologic cancer	7.03e-06	7.02e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—STAT3—hematologic cancer	7.02e-06	7.02e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CD—hematologic cancer	7.01e-06	7e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—NRAS—hematologic cancer	7.01e-06	7e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	6.99e-06	6.98e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—SRC—hematologic cancer	6.97e-06	6.97e-05	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	6.96e-06	6.96e-05	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—PIK3CA—hematologic cancer	6.94e-06	6.93e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	6.94e-06	6.93e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—KRAS—hematologic cancer	6.88e-06	6.87e-05	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	6.87e-06	6.87e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—KRAS—hematologic cancer	6.86e-06	6.85e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.85e-06	6.84e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	6.79e-06	6.79e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—VEGFA—hematologic cancer	6.79e-06	6.78e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—FGF2—hematologic cancer	6.73e-06	6.72e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—STAT3—hematologic cancer	6.73e-06	6.72e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MAPK3—hematologic cancer	6.71e-06	6.7e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—FGF2—hematologic cancer	6.71e-06	6.7e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—NRAS—hematologic cancer	6.71e-06	6.7e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ABCB1—hematologic cancer	6.7e-06	6.69e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—FGF2—hematologic cancer	6.64e-06	6.64e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3R1—hematologic cancer	6.64e-06	6.63e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3R1—hematologic cancer	6.62e-06	6.61e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	6.55e-06	6.55e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MYC—hematologic cancer	6.53e-06	6.52e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TGFB1—hematologic cancer	6.51e-06	6.5e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—NCOR1—hematologic cancer	6.5e-06	6.5e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GSTM1—hematologic cancer	6.5e-06	6.5e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—JAK2—hematologic cancer	6.45e-06	6.44e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—JAK2—hematologic cancer	6.43e-06	6.42e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MAPK3—hematologic cancer	6.43e-06	6.42e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—JAK2—hematologic cancer	6.37e-06	6.36e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—PIK3CA—hematologic cancer	6.32e-06	6.32e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PTEN—hematologic cancer	6.31e-06	6.31e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—PIK3CA—hematologic cancer	6.3e-06	6.3e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MDM2—hematologic cancer	6.3e-06	6.29e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MDM2—hematologic cancer	6.28e-06	6.27e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MYC—hematologic cancer	6.25e-06	6.24e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	6.24e-06	6.23e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TGFB1—hematologic cancer	6.23e-06	6.23e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MDM2—hematologic cancer	6.22e-06	6.21e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MTOR—hematologic cancer	6.13e-06	6.12e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CB—hematologic cancer	6.13e-06	6.12e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CB—hematologic cancer	6.11e-06	6.1e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MTOR—hematologic cancer	6.11e-06	6.1e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	6.05e-06	6.04e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MTOR—hematologic cancer	6.05e-06	6.04e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—KRAS—hematologic cancer	6.03e-06	6.02e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—EP300—hematologic cancer	6.02e-06	6.01e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—HRAS—hematologic cancer	5.85e-06	5.84e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—HRAS—hematologic cancer	5.83e-06	5.83e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	5.78e-06	5.77e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—KRAS—hematologic cancer	5.77e-06	5.77e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CDKN1B—hematologic cancer	5.75e-06	5.74e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—MTHFR—hematologic cancer	5.75e-06	5.74e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CDKN1B—hematologic cancer	5.73e-06	5.73e-05	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—AKT1—hematologic cancer	5.69e-06	5.68e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	5.68e-06	5.67e-05	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—AKT1—hematologic cancer	5.67e-06	5.66e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CASP3—hematologic cancer	5.64e-06	5.63e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IL2—hematologic cancer	5.63e-06	5.62e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CASP3—hematologic cancer	5.62e-06	5.61e-05	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	5.62e-06	5.61e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IL2—hematologic cancer	5.61e-06	5.6e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—IL6—hematologic cancer	5.6e-06	5.59e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—IL6—hematologic cancer	5.58e-06	5.58e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CASP3—hematologic cancer	5.56e-06	5.56e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IL2—hematologic cancer	5.56e-06	5.55e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PIK3CA—hematologic cancer	5.54e-06	5.53e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—IL6—hematologic cancer	5.53e-06	5.52e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCND1—hematologic cancer	5.49e-06	5.48e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—JUN—hematologic cancer	5.47e-06	5.47e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCND1—hematologic cancer	5.47e-06	5.46e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—JUN—hematologic cancer	5.46e-06	5.45e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCND1—hematologic cancer	5.42e-06	5.41e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—JUN—hematologic cancer	5.4e-06	5.4e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TP53—hematologic cancer	5.36e-06	5.35e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	5.31e-06	5.3e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3CA—hematologic cancer	5.31e-06	5.3e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PTEN—hematologic cancer	5.29e-06	5.29e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CDKN1A—hematologic cancer	5.29e-06	5.28e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PTEN—hematologic cancer	5.28e-06	5.27e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	5.24e-06	5.23e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PTEN—hematologic cancer	5.23e-06	5.22e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	5.18e-06	5.17e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	5.17e-06	5.16e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	5.16e-06	5.16e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	5.15e-06	5.14e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TP53—hematologic cancer	5.13e-06	5.13e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—HRAS—hematologic cancer	5.13e-06	5.12e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	5.11e-06	5.11e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	5.1e-06	5.09e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.06e-06	5.06e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—EP300—hematologic cancer	5.05e-06	5.04e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—EP300—hematologic cancer	5.03e-06	5.03e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—EP300—hematologic cancer	4.98e-06	4.98e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SRC—hematologic cancer	4.91e-06	4.9e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—HRAS—hematologic cancer	4.91e-06	4.9e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IL6—hematologic cancer	4.91e-06	4.9e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SRC—hematologic cancer	4.89e-06	4.89e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SRC—hematologic cancer	4.85e-06	4.84e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	4.83e-06	4.82e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	4.78e-06	4.78e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	4.77e-06	4.76e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—STAT3—hematologic cancer	4.74e-06	4.73e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NRAS—hematologic cancer	4.72e-06	4.72e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	4.72e-06	4.72e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—STAT3—hematologic cancer	4.72e-06	4.72e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NRAS—hematologic cancer	4.71e-06	4.7e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IL6—hematologic cancer	4.7e-06	4.69e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	4.67e-06	4.67e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	4.66e-06	4.66e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—AKT1—hematologic cancer	4.53e-06	4.52e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	4.52e-06	4.52e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	4.51e-06	4.5e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CREBBP—hematologic cancer	4.48e-06	4.47e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	4.47e-06	4.46e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CA—hematologic cancer	4.45e-06	4.45e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MYC—hematologic cancer	4.4e-06	4.4e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	4.39e-06	4.38e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MYC—hematologic cancer	4.39e-06	4.38e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	4.38e-06	4.37e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MYC—hematologic cancer	4.34e-06	4.34e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—AKT1—hematologic cancer	4.33e-06	4.33e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	4.33e-06	4.33e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	4.25e-06	4.24e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ALB—hematologic cancer	4.19e-06	4.19e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—KRAS—hematologic cancer	4.07e-06	4.06e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—KRAS—hematologic cancer	4.05e-06	4.05e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	4.01e-06	4.01e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	4.01e-06	4e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	3.74e-06	3.73e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	3.72e-06	3.72e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	3.7e-06	3.7e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	3.69e-06	3.68e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—AKT1—hematologic cancer	3.64e-06	3.63e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TP53—hematologic cancer	3.61e-06	3.61e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TP53—hematologic cancer	3.6e-06	3.6e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TP53—hematologic cancer	3.57e-06	3.56e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—HRAS—hematologic cancer	3.46e-06	3.45e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—HRAS—hematologic cancer	3.44e-06	3.44e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	3.41e-06	3.41e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IL6—hematologic cancer	3.31e-06	3.3e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IL6—hematologic cancer	3.3e-06	3.29e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IL6—hematologic cancer	3.27e-06	3.26e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PTEN—hematologic cancer	3.2e-06	3.19e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—AKT1—hematologic cancer	3.05e-06	3.05e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—EP300—hematologic cancer	3.05e-06	3.05e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—AKT1—hematologic cancer	3.04e-06	3.04e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	3.01e-06	3.01e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	2.26e-06	2.25e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—AKT1—hematologic cancer	1.84e-06	1.84e-05	CbGpPWpGaD
